vs

Side-by-side financial comparison of Akso Health Group (AHG) and MESABI TRUST (MSB). Click either name above to swap in a different company.

Akso Health Group is the larger business by last-quarter revenue ($7.0M vs $3.6M, roughly 1.9× MESABI TRUST). MESABI TRUST runs the higher net margin — 77.1% vs -18.6%, a 95.7% gap on every dollar of revenue.

Akso Health Group is a global healthcare enterprise specializing in the R&D, production, and distribution of generic pharmaceuticals, over-the-counter wellness products, and medical devices. It primarily serves markets in China, Southeast Asia, and North America, with core business segments covering drug manufacturing, medical supply chains, and community healthcare services.

Mesabi Trust is a United States-based royalty trust that holds permanent royalty interests in iron ore mining properties located in Minnesota's Mesabi Range. It earns revenue primarily from royalty payments tied to the production and sale of iron ore products, with core earnings sourced from active mining partners operating on the land it holds interests in, catering to the global steel manufacturing market.

AHG vs MSB — Head-to-Head

Bigger by revenue
AHG
AHG
1.9× larger
AHG
$7.0M
$3.6M
MSB
Higher net margin
MSB
MSB
95.7% more per $
MSB
77.1%
-18.6%
AHG

Income Statement — Q2 FY2026 vs Q3 FY2026

Metric
AHG
AHG
MSB
MSB
Revenue
$7.0M
$3.6M
Net Profit
$-1.3M
$2.8M
Gross Margin
8.9%
77.1%
Operating Margin
-20.5%
Net Margin
-18.6%
77.1%
Revenue YoY
-95.5%
Net Profit YoY
-96.5%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHG
AHG
MSB
MSB
Q4 25
$3.6M
Q3 25
$7.0M
$5.6M
Q2 25
$4.7M
Q1 25
$6.9M
Q4 24
$79.0M
Q3 24
$6.5M
Q2 24
$6.3M
Q1 24
$6.2M
Net Profit
AHG
AHG
MSB
MSB
Q4 25
$2.8M
Q3 25
$-1.3M
$4.7M
Q2 25
$3.6M
Q1 25
$6.1M
Q4 24
$78.3M
Q3 24
$5.4M
Q2 24
$3.5M
Q1 24
$4.7M
Gross Margin
AHG
AHG
MSB
MSB
Q4 25
77.1%
Q3 25
8.9%
84.6%
Q2 25
76.7%
Q1 25
88.5%
Q4 24
99.1%
Q3 24
83.2%
Q2 24
55.7%
Q1 24
75.3%
Operating Margin
AHG
AHG
MSB
MSB
Q4 25
Q3 25
-20.5%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Net Margin
AHG
AHG
MSB
MSB
Q4 25
77.1%
Q3 25
-18.6%
84.6%
Q2 25
76.7%
Q1 25
88.5%
Q4 24
99.1%
Q3 24
83.2%
Q2 24
55.7%
Q1 24
75.3%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHG
AHG
MSB
MSB
Cash + ST InvestmentsLiquidity on hand
$11.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.3M
$21.1M
Total Assets
$212.0M
$26.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHG
AHG
MSB
MSB
Q4 25
Q3 25
$11.1M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AHG
AHG
MSB
MSB
Q4 25
$21.1M
Q3 25
$198.3M
$22.8M
Q2 25
$19.6M
Q1 25
$23.3M
Q4 24
$95.3M
Q3 24
$22.1M
Q2 24
$20.7M
Q1 24
$21.0M
Total Assets
AHG
AHG
MSB
MSB
Q4 25
$26.0M
Q3 25
$212.0M
$24.8M
Q2 25
$27.4M
Q1 25
$101.7M
Q4 24
$100.7M
Q3 24
$26.2M
Q2 24
$25.1M
Q1 24
$26.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHG
AHG
MSB
MSB
Operating Cash FlowLast quarter
$1.2M
$3.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHG
AHG
MSB
MSB
Q4 25
$3.5M
Q3 25
$1.2M
$4.4M
Q2 25
$2.1M
Q1 25
$93.9M
Q4 24
$78.2M
Q3 24
$3.8M
Q2 24
$2.5M
Q1 24
$14.6M
Cash Conversion
AHG
AHG
MSB
MSB
Q4 25
1.27×
Q3 25
0.92×
Q2 25
0.57×
Q1 25
15.48×
Q4 24
1.00×
Q3 24
0.71×
Q2 24
0.72×
Q1 24
3.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons